Mini-trampoline Intervention vs. Nordic Walking: Balance, Fitness and Neuropsychological Effects

Obesity Clinical Trial

— TraWaFit  

Official title:

Comparison of 12-week Mini-trampoline Intervention With a Nordic Walking Intervention: Balance, Fitness and Neuropsychological Effects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02596152
• Other study ID #: EKNZ 2015-231/232
• Status: Completed
• Phase: N/A
• Start date: August 2015
• Est. completion date: September 2017

Study information

• Verified date: November 2020
• Source: University of Basel
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The effects of mini-trampoline training on balance, cardiorespiratory fitness, strength and neuropsychological parameters in an overweight or obese population are unknown. The aim of this 2-arm randomized controlled trial is to compare the effects of a 12-week mini-trampoline training and a 12-week nordic walking training on balance, fitness and strength in overweight/obese individuals.

Description:

A growing body of literature suggests, that obesity is not only associated with medical conditions such as diabetes, but also linked to altered gait, impaired balance and a greater likelihood of falls. Weight reduction has been shown to improve balance controle. Methods to increase physical activity are largely not accepted in this population and those which conserve the musculoskeletal system are rare. Physical activity has been shown to influence mood, quality of life and eating behavior. Mini-trampoline training has been shown to enhance stability and increase fitness.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 54
• Est. completion date: September 2017
• Est. primary completion date: October 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• Age 18-55 years

• Body Mass Index =25 kg/m2

• = 1h regular exercise/ physical activity per week

Exclusion Criteria:

• cardiovascular or other chronic diseases not permitting sports participation

• inability to follow the procedures of the study (e.g. due to dementia)

• neurological disorders limiting balance or medications impairing balance

• hypertensive blood pressure not permitting exercise (>180/100 mmHg)

• medication: beta-blocking agents which reduce cardiac adaption abilities to exercise

• known pregnancy with contraindications for exercise according to the guidelines of the American College of Obstetricians and Gynecologists

Related Conditions & MeSH terms

• Obesity
• Overweight

Intervention

Other:
• mini-trampoline
Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.
• Nordic Walking
Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.

Locations

Country	Name	City	State
Switzerland	University of Basel, Department of Sport, Exercise and Health	Basel

Sponsors (1)

Lead Sponsor	Collaborator
Arno Schmidt-Trucksäss

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postural sway	COPspeed (Center of pressure speed measured on a force plate in cm/sec) measured on a force plate in quiet stance with eyes closed	assessed twice: before and after the intervention (12 weeks)
Secondary	peak oxygen uptake	(VO2 peak in ml/kg/min)	assessed twice: before and after the intervention (12 weeks)
Secondary	submaximal heart rate at 50 Watts	(HR at 50 Watts in beats/min)	assessed twice: before and after the intervention (12 weeks)
Secondary	maximal work	(Watts on bicycle ergometer)	assessed twice: before and after the intervention (12 weeks)
Secondary	dynamic core strength	(Nm/kg on dynamometer)	assessed twice: before and after the intervention (12 weeks)
Secondary	lower body explosive strength	(seconds on chair rise test)	assessed twice: before and after the intervention (12 weeks)
Secondary	lower body functional endurance	(repetitions during 30-second-chair rise test)	assessed twice: before and after the intervention (12 weeks)
Secondary	isokinetic plantar flexion strength	(Nm/kg on dynamometer)	assessed twice: before and after the intervention (12 weeks)
Secondary	functional balance	(cm in reach test)	assessed twice: before and after the intervention (12 weeks)
Secondary	body fat mass	(in kg)	assessed twice: before and after the intervention (12 weeks)
Secondary	waist circumference	(in cm)	assessed twice: before and after the intervention (12 weeks)
Secondary	motivation and barriers	(score on questionnaire)	assessed twice: before and after the intervention (12 weeks)
Secondary	mood	(score on multidimensional mood questionnaire)	assessed twice: before and after the intervention (12 weeks)
Secondary	weight adjusted quality of life	(score on IWQOL questionnaire)	assessed twice: before and after the intervention (12 weeks)
Secondary	body dissatisfaction	(score on Figure Rating Scale)	assessed twice: before and after the intervention (12 weeks)
Secondary	eating behavior	(score on FEV questionnaire)	assessed twice: before and after the intervention (12 weeks)
Secondary	attention	(score on the digit span test)	assessed twice: before and after the intervention (12 weeks)
Secondary	cognitive flexibility	(seconds during the Trail making test)	assessed twice: before and after the intervention (12 weeks)
Secondary	executive planning function	(score in the Tower of London Test (computer based version))	assessed twice: before and after the intervention (12 weeks)
Secondary	behavioral shift and inhibition	(number of mistakes in the Inhib Test (computer based version))	assessed twice: before and after the intervention (12 weeks)
Secondary	body muscle mass	(in kg)	assessed twice: before and after the intervention (12 weeks)